-
Becaplermin, sold
under the
brand name Regranex, is a cicatrizant,
available as a
topical gel.
Regranex is a
human platelet-derived
growth factor indicated...
-
Dexpanthenol D03AX04
Calcium pantothenate D03AX05
Hyaluronic acid D03AX06
Becaplermin D03AX09
Crilanomer D03AX10
Enoxolone D03AX11
Sodium chlorite (tetrachlorodecaoxide)...
- A01AD05
Acetylsalicylic acid A01AD06
Adrenalone A01AD07
Amlexanox A01AD08
Becaplermin A01AD11
Various "ATC (Anatomical
Therapeutic Chemical classification...
-
Berlex Laboratories Inc. In 1997
Chiron provided the
active ingredient,
becaplermin, in Regranex, a
topical treatment for
diabetic foot ulcers, manufactured...
-
Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists:
Becaplermin Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib...
-
Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists:
Becaplermin Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib...
-
Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists:
Becaplermin Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib...
-
Product Manufacturer Drug
Gelator Use
Route REGRANEX gel
Johnson &
Johnson Becaplermin Sodium CMC
Treatment of
diabetic neuropathic ulcers Transdermal Topicort...
-
Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists:
Becaplermin Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib...
-
Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists:
Becaplermin Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib...
